How Abuse-Deterrent Reformulated Opioids Can Stop a Costly Problem: Diversion

In this presentation, Dan Cohen, Executive Vice President, Government & Public Relations, presents on:

Why you should invest in ADFs and the investments made so far
Understanding how ADFs are effective in reducing the diversion of pharmaceutical products
Comparing recent data on drug abuse and diversion before and after formulation
Learning from law enforcement to round out your pharmaceutical landscape

Please note: That all fields marked with an asterisk (*) are required.

First Name *

Last Name *

Job Title *

Company Name *

Email Address *

Telephone *

Mobile Telephone

Country *

Where did you hear about us?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.